Black women in the US have significantly higher breast cancer mortality than White women.
Within biomarker-defined tumor subtypes, disparate outcomes seem to be limited to women …

Importance Though adjuvant endocrine therapy (AET) has proven efficacy in treating
hormone receptor–positive (HR-positive) breast cancer, patient adherence to AET and …

Purpose Adherence and persistence to adjuvant hormone therapy (AHT) are seldom
maintained among early-stage hormone receptor-positive breast cancer (BC) survivors …

Background: Adjuvant endocrine therapy (AET) improves outcomes in women with hormone
receptor–positive (HR+) breast cancer. Suboptimal AET adherence is common, but data are …

Background Adherence to oral endocrine therapy (OET) is crucial in ensuring its maximum
benefit in the prevention and treatment of hormone receptor-positive (HR+) breast cancer …

The COVID-19 pandemic has had critical consequences for cancer care delivery, including
altered treatment protocols and delayed services that may affect patients' quality of life and …

Purpose This retrospective cohort study examined patterns of endocrine therapy initiation
over time and by demographic, tumor, and treatment characteristics. Methods We included …

Purpose The use of surveillance mammography following a breast cancer (BC) diagnosis is
associated with early detection of disease relapse and increased overall survival; yet Black …

Purpose Accounting for endocrine therapy use for breast cancer treatment is important for
studies of survivorship. We evaluated the accuracy of Surveillance, Epidemiology, and End …

Background Adherence to oral endocrine therapy (OET) is crucial in ensuring its maximum
benefit in prevention and treatment of hormone receptor-positive (HR+) breast cancer (BC) …